RxDoctor Payments Data

Jean Bao, MD

Surgery · Palo Alto, CANPI 1447575360

Payments from drug & device makers

$493in general payments, 2019–2025

Across 9 payments — averaging $54.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Focal Therapeutics, Inc.$147
  • Tactile Systems Technology Inc$125
  • Sirius Medical Systems$74
  • Molli Surgical (US) Inc$40
  • Merit Medical Systems Inc$34
  • Coherus Oncology, Inc.$28
  • plus $45 from 2 others

What the payments were for

  • Food & beverage$493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Focal Therapeutics, Inc.1$147
Tactile Systems Technology Inc1$125
Sirius Medical Systems1$74
Molli Surgical (US) Inc1$40
Merit Medical Systems Inc1$34
Coherus Oncology, Inc.2$28
Merck1$27
Myriad Genetic Laboratories, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$493 in reported general payments places this provider in the 30th percentile of 2,363 surgery providers in California.

See all surgery providers in California

Medicare billing

Part B allowed, 2024
$105,550
Medicare patients
243
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl25$46

Paid to pharmacies, not to this prescriber.

Other surgery in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →